Hair Loss Treatment in 2026: The Evidence-Based Decision Framework
With 85% of men and 33% of women experiencing hair loss, the 2026 treatment landscape offers unprecedented options—from new FDA submissions to JAK inhibitors and AI-driven surgical systems. This evidence-based framework cuts through the complexity to match hair loss treatments to your specific situation, stage, budget, and timeline.





